CYTOKINETICS INC
CYTK
80 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 2 9:37 PM | B LYNNE PARSHALL | Proposed Sale | 10,000 | $62.22 | $622.2K | — | View → |
| Mar 2, 2026 | Mar 2 9:29 PM | Lynne B ParshallDirector | Sale | 5,000 | $61.21 | $306.1K | 17,933(D) | View → |
| Mar 2, 2026 | Mar 2 9:28 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 886 | $61.62 | $54.6K | 50,440(D) | View → |
| Feb 5, 2026 | Feb 6 1:17 AM | Andrew CallosEVP, Chief Commercial Officer | Sale | 15,000 | $61.93 | $929.0K | 50,440(D) | View → |
| Feb 2, 2026 | Feb 2 9:40 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 886 | $62.10 | $55.0K | 50,440(D) | View → |
| Jan 2, 2026 | Jan 2 9:34 PM | ANDREW CALLOS | Proposed Sale | 59,570 | $63.54 | $3.8M | — | View → |
| Dec 29, 2025 | Dec 29 9:27 PM | ANDREW CALLOS | Proposed Sale | 1,809 | $63.11 | $114.2K | — | View → |
| Dec 22, 2025 | Dec 22 9:26 PM | WENDELL WIERENGA | Proposed Sale | 20,000 | $62.72 | $1.3M | — | View → |
| Dec 5, 2025 | Dec 5 9:26 PM | ANDREW CALLOS | Proposed Sale | 53,528 | $66.54 | $3.6M | — | View → |
| Dec 2, 2025 | Dec 2 9:25 PM | JOHN T HENDERSON | Proposed Sale | 8,750 | $66.05 | $577.9K | — | View → |
| Dec 1, 2025 | Dec 1 9:21 PM | EDWARD KAYE | Proposed Sale | 28,064 | $68.13 | $1.9M | — | View → |
| Nov 19, 2025 | Nov 19 9:20 PM | B LYNNE PARSHALL | Proposed Sale | 5,000 | $66.16 | $330.8K | — | View → |
| Nov 11, 2025 | Nov 12 12:04 PM | EDWARD KAYE | Proposed Sale | 5,175 | $62.20 | $321.9K | — | View → |
| Oct 27, 2025 | Oct 27 8:27 PM | WENDELL WIERENGA | Proposed Sale | 4,375 | $57.83 | $253.0K | — | View → |
| Oct 21, 2025 | Oct 21 8:20 PM | FADY MALIK | Proposed Sale | 11,000 | $59.35 | $652.9K | — | View → |
| Oct 6, 2025 | Oct 6 8:22 PM | EDWARD KAYE | Proposed Sale | 6,757 | $56.97 | $384.9K | — | View → |
| Oct 1, 2025 | Oct 1 8:34 PM | ROBERT BLUM | Proposed Sale | 15,000 | $54.96 | $824.4K | — | View → |
| Sep 30, 2025 | Sep 30 8:29 PM | EDWARD KAYE | Proposed Sale | 6,695 | $53.89 | $360.8K | — | View → |
| Sep 2, 2025 | Sep 2 8:36 PM | ROBERT HARRINGTON | Proposed Sale | 4,300 | $35.33 | $151.9K | — | View → |
| Sep 2, 2025 | Sep 2 8:28 PM | EDWARD KAYE | Proposed Sale | 6,756 | $35.33 | $238.7K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 27 11:08 PM | Wendell WierengaDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:07 PM | Nancy WysenskiDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 19, 2026 | May 20 8:00 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 47,886(D) | View → |
| May 5, 2026 | May 5 9:35 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 51,386(D) | View → |
| May 5, 2026 | May 5 8:20 PM | Wendell WierengaDirector | Option Exercise | 4,032 | $12.40 | 0(D) | View → |
| May 5, 2026 | May 5 8:15 PM | John T HendersonDirector | Option Exercise | 20,000 | $7.61 | 0(D) | View → |
| May 5, 2026 | May 5 8:11 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 11,333 | $39.13 | 13,070(D) | View → |
| May 1, 2026 | May 4 8:01 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,857 | $37.63 | 0(D) | View → |
| Apr 30, 2026 | Apr 30 8:22 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 54,000(D) | View → |
| Apr 21, 2026 | Apr 21 8:22 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 54,886(D) | View → |
| Apr 7, 2026 | Apr 8 8:18 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 4,500 | $10.60 | 0(D) | View → |
| Mar 15, 2026 | Mar 17 8:11 PM | Robert I BlumDirector, President & CEO | Grant/Award | 113,529 | $60.06 | 111,864(D) | View → |
| Mar 15, 2026 | Mar 17 8:08 PM | Andrew CallosEVP, Chief Commercial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:06 PM | Jeffrey HessekielChief Legal & Admin Officer | Grant/Award | 31,145 | $60.06 | 22,820(D) | View → |
| Mar 15, 2026 | Mar 17 8:05 PM | Sung LeeEVP, Chief Financial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:03 PM | Fady Ibraham MalikEVP Research & Development | Grant/Award | 41,192 | $60.06 | 39,527(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 26,000 | $39.13 | 69,000(D) | View → |
| Mar 2, 2026 | Mar 2 9:28 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 0(D) | View → |
| Feb 5, 2026 | Feb 6 1:17 AM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 84,000(D) | View → |
| Feb 2, 2026 | Feb 2 9:40 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 886(D) | View → |
← Previous
Page 2 of 2